Basit öğe kaydını göster

dc.contributor.authorMizuno, Yoshikuni
dc.contributor.authorDubois, Bruno
dc.contributor.authorBurn, David
dc.contributor.authorGoetz, Christopher
dc.contributor.authorAarsland, Dag
dc.contributor.authorBrown, Richard G.
dc.contributor.authorBroe, Gerald A.
dc.contributor.authorLitvan, Irene
dc.contributor.authorMcKeith, Ian G.
dc.contributor.authorOlanow, C. Warren
dc.contributor.authorPoewe, Werner
dc.contributor.authorSampaio, Cristina
dc.contributor.authorTolosa, Eduardo
dc.contributor.authorEmre, Murat
dc.contributor.authorDickson, Dennis
dc.contributor.authorDuyckaerts, Charles
dc.contributor.authorCummings, Jefferey
dc.contributor.authorGauthier, Serge
dc.contributor.authorKorczyn, Amos
dc.contributor.authorLees, Andrew
dc.contributor.authorLevy, Richard
dc.date.accessioned2021-03-02T22:57:22Z
dc.date.available2021-03-02T22:57:22Z
dc.date.issued2007
dc.identifier.citationDubois B., Burn D., Goetz C., Aarsland D., Brown R. G. , Broe G. A. , Dickson D., Duyckaerts C., Cummings J., Gauthier S., et al., "Diagnostic procedures for Parkinson's disease dementia: Recommendations from the Movement Disorder Society Task Force", MOVEMENT DISORDERS, cilt.22, sa.16, ss.2314-2324, 2007
dc.identifier.issn0885-3185
dc.identifier.othervv_1032021
dc.identifier.otherav_0f9caa8c-8174-4f9c-93fc-51ab100ecb51
dc.identifier.urihttp://hdl.handle.net/20.500.12627/16032
dc.identifier.urihttps://doi.org/10.1002/mds.21844
dc.description.abstractA preceding article described the clinical features of Parkinson's disease dementia (PD-D) and proposed clinical diagnostic criteria for "probable" and "possible" PD-D. The main focus of this article is to operationalize the diagnosis of PD-D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time-consuming. Level I can be used alone or in concert with Level 11, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD-D for clinical monitoring, research studies or pharmacological trials. Level 11 tests can also be proposed when the diagnosis of PD-D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence-based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. (c) 2007 Movement Disorder Society
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp
dc.titleDiagnostic procedures for Parkinson's disease dementia: Recommendations from the Movement Disorder Society Task Force
dc.typeMakale
dc.relation.journalMOVEMENT DISORDERS
dc.contributor.departmentAssistance Publique Hopitaux Paris (APHP) , ,
dc.identifier.volume22
dc.identifier.issue16
dc.identifier.startpage2314
dc.identifier.endpage2324
dc.contributor.firstauthorID185647


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster